Abstract
Friend murine erythroleukaemia (F-MEL) cells are a permanent line of primitive erythroid precursors originally derived from the spleens of mice infected with the Friend strain of murine leukaemia virus1. F-MEL cells differentiate in vitro in response to various chemical inducers1,2. Concomitantly with induction, a biphasic regulation of c-myc oncogene transcripts is observed3. Within one hour of the addition of dimethyl sulphoxide (DMSO) or hypoxan-thine (Hyp), the levels of c-myc transcripts fall dramatically and remain virtually undetectable for the next few hours. Between 8 and 24 hours after induction, c-myc transcripts return to pre-induction levels and then decline again between 3 and 5 days as most of the cells undergo terminal differentiation. To explore the potential relationship between c-myc expression and F-MEL terminal differentiation, we have investigated here whether reversing the early fluctuations in c-myc transcript levels affects the ability of F-MEL cells to differentiate. We therefore constructed an amplifiable plasmid vector containing a full-length mouse c-myc complementary DNA and introduced it stably into recipient F-MEL cells. The exogenous c-myc sequences are transcribed in F-MEL cells and the transcript levels do not change significantly in response to inducing agents. The net result is continued c-myc expression following DMSO or Hyp induction and a complete or partial inhibition of F-MEL differentiation.
Similar content being viewed by others
References
Marks, P. O. & Rifkind, R. A. A. Rev. Biochem. 47, 419–448 (1978).
Friend, C., Scher, W., Holland, J. G. & Sato, T. Proc. natn. Acad. Sci. U.S.A 68, 378–382 (1971).
Lachman, H. M. & Skoultchi, A. I. Nature 310, 592–594 (1984).
Simonsen, C. C. & Levinson, A. D. Proc. natn. Acad. Sci. U.S.A 80, 2495–2499 (1983).
Orkin, S. H., Harosi, F. I. & Leder, P. Proc. natn. Acad. Sci U.S.A 72, 98–102 (1975).
Collins, S. & Groudine, M. Nature 298, 679–681 (1982).
Nepveu, A., Fahrlander, P. D., Yang, J.-Q. & Marcu, K. B. Nature 319, 440–443 (1985).
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. & Bishop, J. M. Science 224, 1121–1124 (1984).
Rechavi, G., Givol, D. & Canaani, E. Nature 300, 607–611 (1982).
Heisterkamp, N. et al. Nature 306, 239–242 (1983).
Leder, P. et al. Science 222, 765–771 (1983).
Muller, R., Curran, T., Muller, D. & Guilbert, L. Nature 314, 546–548 (1985).
Gonda, T. J. & Metcalf, D. Nature 310, 249–251 (1984).
Slamon, D. J. & Cline, M. J. Proc. natn. Acad. Sci. U.S.A 81, 7141–7145 (1984).
Greenberg, M. E. & Ziff, E. B. Nature 311, 433–438 (1984).
Persson, H. & Leder, P. Science 225, 718–721 (1984).
Ralston, R. & Bishop, J. M. Nature 306, 803–806 (1983).
Kingston, R. E., Baldwin, A. S. & Sharp, P. A. Nature 312, 280–282 (1984).
Kingston, R. E., Baldwin, A. S. & Sharp, P. A. Cell 41, 3–5 (1985).
Gusella, J., Geller, R., Clarke, B., Weeks, V. & Housman, D. Cell 9, 221–229 (1976).
Falcone, G., Tato, F. & Alema, S. Proc. natn. Acad. Sci. U.S.A 82, 426–430 (1985).
Noda, M. et al. Nature 318, 73–75 (1985).
Waneck, G. L., Keyes, L. & Rosenberg, N. Cell 44, 337–344 (1986).
Piechaczyk, M., Yang, J.-Q., Blanchard, J.-M., Jenteur, P. & Marcu, K. B. Cell 42, 589–597 (1985).
Keath, E. J., Caimi, P. G. & Cole, M. D. Cell 39, 339–348 (1984).
Coppola, J. A. & Cole, M. D. Nature 320, 760–763 (1986).
Maniatis, T., Fritsch, E. F. & Sambrook, J. in Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, New York, 1982).
Southern, P. J. & Berg, P. J. Molec. appl Genet. 1, 327–341 (1982).
Stanton, L. W., Fahrlander, P. D., Tesser, P. M. & Marcu, K. B. Nature 310, 423–425 (1984).
Battey, J. et al. Cell 34, 779–787 (1983).
Potter, H., Weir, L. & Leder, P. Proc. natn. Acad. Sci. U.S.A 81, 7161–7165 (1984).
Prochownik, E. V. Nature 316, 845–848 (1985).
Prochownik, E. V. & Orkin, S. H. J. biol. Chem. 295, 15386–15392 (1984).
Favaloro, J., Treisman, R. & Kamen, R. Meth. Enzym. 65, 718 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prochownik, E., Kukowska, J. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 322, 848–850 (1986). https://doi.org/10.1038/322848a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/322848a0
- Springer Nature Limited
This article is cited by
-
MYC in liver cancer: mechanisms and targeted therapy opportunities
Oncogene (2023)
-
MYC oncogene in myeloid neoplasias
Clinical and Translational Oncology (2013)
-
Reflecting on 25 years with MYC
Nature Reviews Cancer (2008)
-
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
Leukemia (2006)
-
Regulation of reactive oxygen species, DNA damage and c-Myc function by peroxiredoxin 1
Oncogene (2005)